Benzinga - by Avi Kapoor, Benzinga Staff Writer.
Shares of 4D Molecular Therapeutics, Inc. (NASDAQ: FDMT) rose sharply in today’s pre-market trading.
4DMT presented interim data from randomized Phase 2 PRISM clinical trial of intravitreal 4D-150 demonstrating favorable tolerability & clinical activity in wet AMD.
4D Molecular Therapeutics shares jumped 20.1% to $21.01 in pre-market trading
Here are some other stocks moving in pre-market trading.
Gainers
- Chenghe Acquisition Co. (NASDAQ: CHEA) gained 68.1% to $9.23 in pre-market trading after dipping around 46% on Friday.
- Tritium DCFC Limited (NASDAQ: DCFC) shares jumped 51.9% to $0.1990 in pre-market trading. Tritium DCFC said the company was the top-awarded fast charger manufacturer for the first round of the State of Tennessee’s National Electric Vehicle Infrastructure (NEVI) Formula Program.
- YanGuFang International Group Co., Ltd. (NASDAQ: YGF) gained 27.4% to $0.7641 in pre-market trading after falling around 19% on Friday.
- Magic Empire Global Limited (NASDAQ: MEGL) shares gained 21.6% to $0.9841 in pre-market trading.
- CalAmp Corp. (NASDAQ: CAMP) shares gained 16.8% to $3.61 in pre-market trading after dipping around 14% on Friday. CalAmp recently announced a 1-for-23 reverse stock split.
- 2U, Inc. (NASDAQ: TWOU) shares gained 16.1% to $ 0.9199 in pre-market trading after declining over 8% on Friday.
- Cadrenal Therapeutics, Inc. (NASDAQ: CVKD) shares rose 14.8% to $1.55 in pre-market trading.
- Atara Biotherapeutics, Inc. (NASDAQ: ATRA) shares rose 14.7% to $1.40 in pre-market trading after surging 47% on Friday.
- Griid Infrastructure Inc. (NASDAQ: GRDI) shares rose 14.4% to $2.38 in pre-market trading after dipping more than 50% on Friday.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.
Losers- Cano Health, Inc. (NYSE: CANO) shares dipped 60% to $0.92 in pre-market trading. Cano Health initiated prearranged voluntary Chapter 11 proceedings in the U.S. Bankruptcy Court for the District of Delaware.
- DMK Pharmaceuticals Corporation (NASDAQ: DMK) shares fell 44.4% to $0.2889 in pre-market trading. The company filed voluntary petitions under Chapter 11 of the U.S. Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware.
- NanoString Technologies, Inc. (NASDAQ: NSTG) fell 37% to $0.2951. The company initiated a chapter 11 restructuring proceeding in the United States Bankruptcy Court for the District of Delaware.
- Bit Brother Limited (NASDAQ: BETS) shares fell 23% to $2.31 in pre-market trading. Bit Brother received delisting notice from the Nasdaq.
- NexImmune, Inc. (NASDAQ: NEXI) declined 12% to $11.09 in pre-market trading. NexImmune announced a $3.67 million registered direct offering priced at-the-market under Nasdaq rules.
- SCWorx Corp. (NASDAQ: WORX) fell 10.6% to $1.10 in pre-market trading after dipping 8% on Friday.
- Atreca, Inc. (NASDAQ: BCEL) shares declined 9.5% to $0.2489 in pre-market trading.
- Biora Therapeutics, Inc. (NASDAQ: BIOR) shares fell 9.4% to $0.85 in pre-market trading.
- CCSC Technology International Holdings Limited (NASDAQ: CCTG) shares dipped 8.7% to $4.72 in pre-market trading after surging 32% on Friday.
- Banco Santander, S.A. (NYSE: SAN) shares declined 6.9% to $3.89 in pre-market trading. , Iranian entities reportedly used accounts at Lloyds Banking Group and Banco Santander to evade U.S. sanctions.
Now Read This: McDonald's, Caterpillar And 3 Stocks To Watch Heading Into Monday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or
remove ads
.